Noseda Diego Gabriel, Recúpero Matías Nicolás, Blasco Martín, Ortiz Gastón Ezequiel, Galvagno Miguel Angel
Instituto de Investigaciones Biotecnológicas-Instituto Tecnológico de Chascomús (IIB-INTECH), Universidad Nacional de San Martín (UNSAM) - Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), San Martín, Buenos Aires, Argentina.
Protein Expr Purif. 2013 Dec;92(2):235-44. doi: 10.1016/j.pep.2013.08.018. Epub 2013 Oct 16.
The codon sequence optimized bovine prochymosin B gene was cloned under the control of the alcohol oxidase 1 promoter (AOX1) in the vector pPIC9K and integrated into the genome of the methylotrophic yeast Pichia (Komagataella) pastoris (P. pastoris) strain GS115. A transformant clone that showed resistance to over 4 mg G418/ml and displayed the highest milk-clotting activity was selected. Cell growth and recombinant bovine chymosin production were optimized in flask cultures during methanol induction phase achieving the highest coagulant activity with low pH values, a temperature of 25°C and with the addition of sorbitol and ascorbic acid at the beginning of this period. The scaling up of the fermentation process to lab-scale stirred bioreactor using optimized conditions, allowed to reach 240 g DCW/L of biomass level and 96 IMCU/ml of milk-clotting activity. The enzyme activity corresponded to 53 mg/L of recombinant bovine chymosin production after 120 h of methanol induction. Western blot analysis of the culture supernatant showed that recombinant chymosin did not suffer degradation during the protein production phase. By a procedure that included high performance gel filtration chromatography and 3 kDa fast ultrafiltration, the recombinant bovine chymosin was purified and concentrated from fermentation cultures, generating a specific activity of 800 IMCU/Total Abs(280 nm) and a total activity recovery of 56%. This study indicated that P. pastoris is a suitable expression system for bioreactor based fed-batch fermentation process for the efficient production of recombinant bovine chymosin under methanol-inducible AOX1 promoter.
将密码子序列优化的牛凝乳酶原B基因克隆到载体pPIC9K中,置于醇氧化酶1启动子(AOX1)的控制下,并整合到甲基营养型酵母巴斯德毕赤酵母(Komagataella)(毕赤酵母)GS115菌株的基因组中。筛选出对超过4 mg G418/ml具有抗性且凝乳活性最高的转化子克隆。在甲醇诱导阶段,通过摇瓶培养对细胞生长和重组牛凝乳酶的生产进行了优化,在低pH值、25°C的温度以及在此阶段开始时添加山梨醇和抗坏血酸的条件下,实现了最高的凝结活性。使用优化条件将发酵过程放大到实验室规模的搅拌式生物反应器,可达到240 g DCW/L的生物量水平和96 IMCU/ml的凝乳活性。甲醇诱导120小时后,酶活性相当于53 mg/L的重组牛凝乳酶产量。对培养上清液的蛋白质免疫印迹分析表明,重组凝乳酶在蛋白质生产阶段未发生降解。通过包括高效凝胶过滤色谱和3 kDa快速超滤在内的方法,从发酵培养物中纯化并浓缩了重组牛凝乳酶,产生了800 IMCU/总吸光度(280 nm)的比活性和56%的总活性回收率。本研究表明,毕赤酵母是一种适合基于生物反应器的补料分批发酵过程的表达系统,可在甲醇诱导的AOX1启动子下高效生产重组牛凝乳酶。